Fluvoxamine and graded psychotherapy in the treatment of bulimia nervosa: a randomized, double-blind, placebo-controlled, multicenter study of short-term and long-term pharmacotherapy combined with a stepped care approach to psychotherapy.
Schmidt
Ulrike
U
Cooper
Peter J
PJ
Essers
Hans
H
Freeman
Christopher P L
CP
Holland
Robert L
RL
Palmer
Robert L
RL
Shur
Eric
E
Russell
Gerald F M
GF
Bowler
Clare
C
Coker
Sian
S
Geddes
John R
JR
Mackenzie
Fiona
F
Munro
Jenny
J
Newton
Richard
R
Tiller
Jane
J
Tattersall
Mark L
ML
Vize
Christine
C
Webster
Jenny
J
D000293:Adolescent; D000328:Adult; D002032:Bulimia / Q000628:therapy*; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced; D005260:Female; D016666:Fluvoxamine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008134:Long-Term Care; D008875:Middle Aged; D011446:Prospective Studies; D011614:Psychotherapy, Brief; D018570:Risk Assessment; D055502:Secondary Prevention; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D016666:Fluvoxamine; D017367:Selective Serotonin Reuptake Inhibitors